Michael Costa | Executive Vice President of Finance |
Rick Matros | Chairman and Chief Executive Officer |
Harold Andrews | Chief Financial Officer |
Chad Vanacore | Stifel Nicolaus |
Juan Sanabria | Bank of America Merrill Lynch |
Smedes Rose | Citi |
Daniel Bernstein | Capital One |
Eric Fleming | SunTrust Robinson Humphrey |
Philip DeFelice | Wells Fargo Securities |
Good day | ladies and gentlemen - and welcome to the Sabra Health Care REIT third quarter 2017 earnings conference call. This call is being recorded. I would now like to turn the call over to Michael Costa - Executive Vice President of Finance. Please go ahead - Mr. Costa. |
Thank you.
Before we begin, I want to remind you that we will be making forward-looking statements in our comments and in response to your questions concerning our expectations regarding our acquisition, disposition and investment plans. The status of our integration efforts with respect to CCP and with respect to other investments this year, our expectations regarding our portfolio repositioning with certain legacy CCP tenants, our expectations regarding our financing plans, and our expectations regarding our future result of operations. These forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including the risks listed in our Form 10-K for the year ended December 31, 2016, and in our Form 10-Q that was filed with the SEC yesterday as well as in our earnings press release included as Exhibit 99.1 to the Form 8-K we furnished to the SEC yesterday, as well as in our earnings press release included as Exhibit 99.1 to the Form 8-K, we furnished to the SEC yesterday. We undertake no obligation to update our forward-looking statements to reflect subsequent events or circumstances, and you should not assume later in the quarter that the comments we make today are still valid.